Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2

Cellular and Molecular Life Sciences

Volumn 65, Issue 10, 2008, Pages 1596-1608

  Todesco, L ^a   Bur, D ^b   Brooks, H ^a   Torok M ^a   Landmann, L ^c   Stieger, B ^d   Krahenbuhl S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ACTELION PHARMACEUTICALS LTD   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Acylcarnitines; Drug carnitine interactions; hOCTN2; Secondary carnitine deficiency; Stable transfection; Verapamil

Indexed keywords

CARNITINE; MESSENGER RNA; PROTEIN OCTN 2;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL LINE; COMPUTER MODEL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIBODIES; CARNITINE; CELL LINE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MYOBLASTS, SKELETAL; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 44449145850     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8065-7     Document Type: Article

References (39)

1. Bremer, J. (1983) Carnitine - Metabolism and functions. Physiol. Rev. 63, 1420-1480.
2. Fritz, I. B. (1955) The effects of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates. Acta Physiol. Scand. 34, 367-385.
3. Bremer, J. (1990) The role of carnitine in intracellular metabolism. J. Clin. Chem. Clin. Biochem. 28, 297-301.
4. Treem, W. R., Stanley, C. A., Finegold, D. N., Hale, D. E. and Coates, P. M. (1988) Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N. Engl. J. Med. 319, 1331-1336.
5. Tamai, I., China, K., Sai, Y., Kobayashi, D., Nezu, J., Kawahara, E. and Tsuji, A. (2001) Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim. Biophys. Acta 1512, 273-284.
6. Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y. and Tsuji, A. (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273, 20378-20382.
7. Wu, X., Huang, W., Prasad, P. D., Seth, P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J. and Ganapathy, V. (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J. Pharmacol. Exp. Ther. 290, 1482-1492.
8. Wu, X., Prasad, P. D., Leibach, F. H. and Ganapathy, V. (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem. Biophys. Res. Commun. 246, 589-595.
9. Scholte, H. R., Rodrigues Pereira, R., de Jonge, P. C., Luyt-Houwen, I. E., Hedwig, M., Verduin, M. and Ross, J. D. (1990) Primary carnitine deficiency. J. Clin. Chem. Clin. Biochem. 28, 351-357.
10. Burwinkel, B., Kreuder, J., Schweitzer, S., Vorgerd, M., Gempel, K., Gerbitz, K. D. and Kilimann, M. W. (1999) Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: A novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality. Biochem. Biophys. Res. Commun. 261, 484-487.
11. Mayatepek, E., Nezu, J., Tamai, I., Oku, A., Katsura, M., Shimane, M. and Tsuji, A. (2000) Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency. Hum. Mutat. 15, 118.
12. Nezu, J., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H., Hashimoto, N., Nikaido, H., Sai, Y., Koizumi, A., Shoji, Y., Takada, G., Matsuishi, T., Yoshino, M., Kato, H., Ohura, T., Tsujimoto, G., Hayakawa, J., Shimane, M. and Tsuji, A. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 21, 91-94.
13. Rahbeeni, Z., Vaz, F. M., Al-Hussein, K., Bucknall, M. P., Ruiter, J., Wanders, R. J. and Rashed, M. S. (2002) Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency. J. Inherit. Metab. Dis. 25, 363-369.
14. Tang, N. L., Ganapathy, V., Wu, X., Hui, J., Seth, P., Yuen, P. M., Wanders, R. J., Fok, T. F. and Hjelm, N. M. (1999) Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum. Mol. Genet. 8, 655-660.
15. Vaz, F. M., Scholte, H. R., Ruiter, J., Hussaarts-Odijk, L. M., Pereira, R. R., Schweitzer, S., de Klerk, J. B., Waterham, H. R. and Wanders, R. J. (1999) Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency. Hum. Genet. 105, 157-161.
16. Lamhonwah, A. M. and Tein, I. (1998) Carnitine uptake defect: Frameshift mutations in the human plasmalemmal carnitine transporter gene. Biochem. Biophys. Res. Commun. 252, 396-401.
17. Wang, Y., Ye, J., Ganapathy, V. and Longo, N. (1999) Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc. Natl. Acad. Sci. USA 96, 2356-2360.
18. Makhseed, N., Vallance, H. D., Potter, M., Waters, P. J., Wong, L. T., Lillquist, Y., Pasquali, M., Amat di San Filippo, C. and Longo, N. (2004) Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy. J. Inherit. Metab. Dis. 27, 778-780.
19. Rijlaarsdam, R. S., van Spronsen, F. J., Bink-Boelkens, M. T., Reijngoud, D. J., Wanders, R. J., Niezen-Koning, K. E., Van der Sluijs, F. H., Dorland, B. and Beaufort-Krol, G. C. (2004) Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Pacing Clin. Electrophysiol. 27, 675-676.
20. Famularo, G., De Simone, C., Trinchieri, V. and Mosca, L. (2004) Carnitines and its congeners: A metabolic pathway to the regulation of immune response and inflammation. Ann. N. Y. Acad. Sci. 1033, 132-138.
21. Ferrari, R., Merli, E., Cicchitelli, G., Mele, D., Fucili, A. and Ceconi, C. (2004) Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: A review. Ann. N. Y. Acad. Sci. 1033, 79-91.
22. Ng, C. M., Blackman, M. R., Wang, C. and Swerdloff, R. S. (2004) The role of carnitine in the male reproductive system. Ann. N. Y. Acad. Sci. 1033, 177-188.
23. Ohtani, Y., Endo, F. and Matsuda, I. (1982) Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J. Pediatr. 101, 782-785.
24. Kuntzer, T., Reichmann, H., Bogousslavsky, J. and Regli, F. (1990) Emetine-induced myopathy and carnitine deficiency. J. Neurol. 237, 495-496.
25. Holme, E., Greter, J., Jacobson, C. E., Lindstedt, S., Nordin, I., Kristiansson, B. and Jodal, U. (1989) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2, 469-473.
26. Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J. I., Oku, A., Sai, Y., Shimane, M. and Tsuji, A. (1999) Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance. J. Pharmacol. Exp. Ther. 291, 778-784.
27. Ganapathy, M. E., Huang, W., Rajan, D. P., Carter, A. L., Sugawara, M., Iseki, K., Leibach, F. H. and Ganapathy, V. (2000) Beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J. Biol. Chem. 275, 1699-1707.
28. Spaniol, M., Brooks, H., Auer, L., Zimmermann, A., Solioz, M., Stieger, B. and Krahenbuhl, S. (2001) Development and characterization of an animal model of carnitine deficiency. Eur. J. Biochem. 268, 1876-1887.
29. +/taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107, 1781-1787.
30. Salmon, P., Oberholzer, J., Occhiodoro, T., Morel, P., Lou, J. and Trono, D. (2000) Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol. Ther. 2, 404-414.
31. Allen, F. H. and Motherwell, W. D. (2002) Applications of the Cambridge Structural Database in organic chemistry and crystal chemistry. Acta Crystallogr. B 58, 407-422.
32. O'Neil, M. J. (2006) The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals. John Wiley & Sons, New York.
33. Brass, E. P. and Hoppel, C. L. (1978) Carnitine metabolism in the fasting rat. J. Biol. Chem. 253, 2688-2693.
34. Wagner, C. A., Lukewille, U., Kaltenbach, S., Moschen, I., Broer, A., Risler, T., Broer, S. and Lang, F. (2000) Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am. J. Physiol. Renal Physiol. 279, F584-591.
35. Sekine, T., Kusuhara, H., Utsunomiya-Tate, N., Tsuda, M., Sugiyama, Y., Kanai, Y. and Endou, H. (1998) Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine. Biochem. Biophys. Res. Commun. 251, 586-591.
36. Georges, B., Galland, S., Rigault, C., Le Borgne, F. and Demarquoy, J. (2003) Beneficial effects of L-carnitine in myoblastic C2C12 cells. Interaction with zidovudine. Biochem. Pharmacol. 65, 1483-1488.
37. Kido, Y., Tamai, I., Ohnari, A., Sai, Y., Kagami, T., Nezu, J., Nikaido, H., Hashimoto, N., Asano, M. and Tsuji, A. (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J. Neurochem. 79, 959-969.
38. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. and Bourne, P. E. (2000) The Protein Data Bank. Nucleic Acids Res. 28, 235-242.
39. Rigault, C., Dias, J. V., Demarquoy, J. and Le Borgne, F. (2008) Characteristics of L-carnitine import into heart cells. Biochimie 90, 542-546.